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Summary: It has been reported that the urine of patients with prolidase deficiency contains various iminodi-
peptides with a carboxyl-terminal proline (hydroxyproline). These iminodipeptides have hitherto been detected
indirectly by acid hydrolysis or enzymatic digestion, followed by amino acid analysis. In the present study, it
was shown that X-Pro could be distinguished from Pro-X when the iminodipeptides were analysed directly
by liquid chromatography coupled with atmospheric pressure ionization mass Spectrometry (LC/API-MS),
with scanning of the protonated molecule ions ([M + H]+). The same procedure also successfully quantified
urinary iminodipeptides from patients with prolidase deficiency. A quantitative investigation of two siblings
with prolidase deficiency revealed that the patient with severe clinical symptoms excreted more iminodipeptides
than the other who did not have serious symptoms. LC/API-MS also revealed iminodipeptides (Gly-Hyp and
Pro^Hyp) in the urine of the mother of the patients and in normal volunteers. Patients excreted much more
Pro-Hyp than normal volunteers, whereas no quantitative differences were found between the mother and
controls. In patients, the excretion of large quantities of X-Pro is due to their very low prolidase activity
towards this type of substrate. In the erythrocytes of patients, prolidase activity towards X-Hyp was extremely
low; even in the mother and normal volunteers, it was remarkably low in comparison with the activity against
X-Pro.
Introduction - . - t , . , , , - j i_ j ι ·the ammo acids liberated by acid hydrolysis or en-
Prolidase (EC 3.4.13.9)1) is expressed in all human zymatic digestion, using an amino acid analyser (3,
tissues, and it catalyses the hydrolysis of iminodipep- 6, 7) or isotachophoresis (8). These methods gave
tides with a C-terminal prolyl residue. Prolidase de- only indirect qualitative analyses, and an exact iden-
ficiency (1 — 5) is a rare autosomal recessive disease tification and quantification have never been re-
affecting collagen metabolism, characterized by ported.
chronic ulcerative dermatitis and mental retardation. TT. , „ ,. . , ,
It has been reported that patients with prolidase de- Hlgh Performance hqmd chromatography (HPLC) is
ficiency, initially named iminopeptiduria, excrete large °ne °f the ™st f^ive means of separating peptide
amounts of iminodipeptides containing a C-terminal IBCrtuiei . <9) and HPLC connected to atmospheric
proline or hydroxyproline in the urine (6, 7). Urinary Pressure '°nizat'on ma*> Spectrometry (LC/API-MS)
iminodipeptides have been identified by analysis of !«» »ceiuy attracted considerable attention as a new
analytical method in various fields (10, 17). In con-
_ trast to gas chromatography-mass Spectrometry, sam-
') Enzyme: Prolidase (peptidase D, imidodipeptidase, EC P'es ^° not nee<^ to be derivatized for LC/API-MS,
3.4.13.9) which can rapidly analyse even substances easily af-
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fected by heat. This procedure shows promise for the
analyses of compounds in biological samples. A pre-
vious paper (11) reported that LC/API-MS could
directly detect various synthetic and urinary imino-
dipeptides by scanning the protonated molecule ions
([M + H]+). In the present study it was investigated
whether authentic iminodipeptides containing a C-
terminal proline could be distinguished from those
containing an N-terminal proline, using LC/API-MS.
The procedure was also used for the quantitative
analyses of the urinary iminodipeptides in prolidase
deficiency. Urine samples from the mother of affected
patients and from normal volunteers were also
scanned for iminodipeptides.
It was discovered by Powell et al. that iminopeptiduria
was the result of an enzyme defect, and that prolidase
deficiency could be diagnosed by the assay of proli-
dase activity in erythrocytes, leukocytes and cultured
skin fibrobi sts. Furthermore, two isozymes of prol-
idase (prolidase I and II) in normal humans have been
studied. Prolidase I has a relative molecular mass of
about 112000 and the highest activity towards Gly-
Pro, whereas prolidase II has a relative molecular
mass of about 185000 and is mainly active towards
Met-Pro. Characteristics of the isozymes in patients
and controls have been discussed in detail (12—16).
The present paper also reports the prolidase activities
for X-Hyp in patients, in their mother and in controls,
which are closely correlated with the quantities of X-
Hyp excreted in the urine.
Materials and Methods
Reagents
Synthetic iminodipeptides containing a C-terminal proline or
hydroxyproline (Gly-Pro, Ala-Pro, Val-Pro, Leu-Pro, Pro-Pro,
Ser-Pro, Gly-Hyp and Pro-Hyp) and iminodipeptides contain-
ing an N-terminal proline (Pro-Gly, Pro-Ala and Pro-Leu) were
purchased from Sigma Chemical Company (St. Louis, MO,
USA). The protein assay kit was from Pierce (Rockford, IL,
USA), and the urinary creatinine assay kit was from Wako
Pure Chemical Industries Ltd. (Osaka, Japan). All other chem-
icals were of analytical grade.
Apparatus
A Hitachi L-6200 high-performance liquid Chromatograph
(HPLC) was connected to a Hitachi M-80B double-focussing
mass spectrometer through an atomospheric pressure ionization
interface (11, 17). LC/API-MS data were obtained with a Hi-
tachi M-0101 data acquisition system. Qualitative and quanti-
tative analyses of a variety of iminodipeptides were carried out
under the following conditions. Inertsil ODS reverse-phase
packed columns (4.6 mm ID χ 150 mm or 4.6 mm ID χ 250
mm) from Gasukuro Kogyo Ltd. (Tokyo, Japan) were used for
the HPLC. Trifluoroacetic acid (lg/1): methanol (75 + 25, by
vol.) was used as the mobile phase at a flow rate of 0.9 ml/
min. Nebulizer temperature, desolvator temperature and drift
voltage were 255 °C, 390 °C and 225 V, respectively.
Samples
Blood was taken from two patients (sisters) with prolidase
deficiency, from their mother and from controls (laboratory
personnel) into heparinized tubes. The erythrocytes were iso-
lated by Umemurcfs method (4) and stored at — 80 °C until
use. Urine samples from patients, their mother and controls
were taken into bottles containing a small amount of 2 mol/1
hydrochloric acid and toluene, and kept at —20 °C until use.
Isolation of iminodipeptides from urine
Urine samples (3 ml) from the two patients, their mother and
normal volunteers were weakly acidified with 2 mol/1 acetic acid
and filtered. The filtrate was transferred to a column (0.9 χ 20
cm) containing a cation-exchange resin (Diaion SK-1, Hrform,
100 ~ 200 mesh, Mitsubishi Kasei Kogyo Ltd., Tokyo, Japan),
washed with 30 ml of water, and eluted with 30 ml of 2 rnol/1
ammonia. The eluate was evaporated to dryness under reduced
pressure. The residue was dissolved in 1 ml of water, then
subjected to LC/API-MS. The creatinine concentration in each
urine sample was determined using the kit described above.
Assay of prolidase activity
Erythrocyte lysates were prepared from the heparinized blood
of patients and normal volunteers according to Umemurcfs
method (4). A mixture containing 10 μΐ of diluted erythrocyte
lysates, 10 μΐ of 10 mmol/1 MnCl2 and 80 μΐ of 50 mmol/1 Tris-
HC1 (pH 7.8) was preincubated for 10 rnin at 37 °C, then
incubated with 100 μΐ of 10 mmol/1 substrate (X^Pro) in
1 mmol/1 MnCl2 for 30 min at 37 °C. The reaction was termi-
nated by the addition of 200 μΐ of 100 g/1 trichloroacetic acid
solution. After 10 min at 90 °C with Chinarcfs reagent (18)
which consisted of liinhydrin, phosphoric acid and acetic acid,
liberated proline was estimated by spectrophotometry (wave-
length: 515 nm). The activity towards X-Hyp was assayed
similarly, but after the addition of trichloroacetic acid was
centrifuged at 3000 min"1 for 5 min. Supernatant (0.5 ml) was
then incubated with 2.5 g/1 copper sulphate, 100 g/1 sodium
hydroxide and 1.8 mol/1 hydrogen peroxide (0.5 ml of each) for
5 min at room temperature, then for 5 min at 80 °C. After
cooling the mixture to 0 °C, 2 ml of 0.75 mol/1 sulphuric acid
and 1 ml of 50 g/1 /7-dimethyl-aminobenzaldehyde were added
and the mixture was incubated for 10 min at 70 °C. The ab-
sorbance of the solution was measured at 575 nm.
Results
The sensitive detection of authentic iminodipeptides
containing C-terminal proline by scanning their pro-
tonated molecule ions ([M + H]+) by LC/API-MS
has been reported previously (11). There are two types
of imiriodipeptide, i. e. with a C-terminal or an N-
terminal proline. Thus we determined whether LC/
API-MS could distinguish iminodipeptides containing
a C-terminal from those containing an N-terminal
proline. The iminodipeptide pairs Pro-Gly/Gly-Pro,
Pro-Ala/Ala-Pro and Pro-Leu/Leu-Pro have the same
protonated molecule mass (m/e) of 173, 187 and 229
respectively. The mass chromatograms and mass spec-
tra of these pairs are presented in figure 1. The two
peaks of each pair were clearjy separated, showing
the difference of retention time on mass chromato-
grams. Pro-Gly and Pro-Ala were eluted earlier than
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Fig. 1. Mass chromatograms and mass spectra of a mixture of authentic Pro-Gly and Gly-Pro (a-(a),(b): Mr 172), Pro-Ala and
Ala-Pro (b-(a),(b): Λ/Γ186), Leu-Pro and Pro-Leu (C-(a),(b): Λ/Γ228). * and ** in the mass spectra indicate the proline
residue + 2H ions and [M -I- H]+ - H2O ions, respectively. TIC stands for total ion chromatogram. These analyses were
carried out over a mass range of 0 to 500, with a scan rate of 4.0 s.
Gly-Prp and Ala^Pro, respectively, whereas Pro-Leu
was eluted later than Leu-Pro. For example, compar-
ison of the mass spectra of Pro-Gly and Gly-Pro
shows that only Gly-Pro produces appreciable quan-
tities of both the [M + H]+ - H2O ion** (m/z: 155)
and the proline residue + 2H ion* (m/z: 116), in
addition to the base peak ion [M + H]+. Ala-Pro and
Leu-Pro also formed an [M + H]+ - H2O ion** and
the proline residue + 2H ion* (fig. 1). The previous
report (11) showed the peaks produced by various
Eur. J. Clin. Chem. Clin. Biochem. / Vol. 31,1993 / No. 5
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urinary iminodipeptides from a patient with prolidase
deficiency. On the basis of the present study, it now
seems certain that those urinary iminodipeptides con-
tained a C-terminal proline.
Good correlations were obtained between the concen-
trations of synthetic iminodipeptides and the peak
areas on mass chromatograms, so that the calibration
curves were linear (fig. 2). Quantification of some
standard iminodipeptides applied to the cation-ex-
change columns demonstrated approximately 95%
recovery, and standards added to normal urine also
showed a recovery of 90 ~ 95% (data not shown).
Urine samples from patients with prolidase deficiency
were passed through the column, and the effluent was











SIM). The resulting chromatograrn showed clear
peaks of iminodipeptides with no interference from
other peaks (fig. 3). Quantification of X-Pro based
on peak areas is shown in table 1-A. Gly-Hyp
([M + H]+: 189) and Pro-Hyp '([M + H]+: 229) are
excreted in the urine of a patient with prolidase de-
ficiency (11). However, scans of the urine sample from
the patients' mother and samples from normal vol-
unteers at [M + H]+ 189 and 229, revealed clear
peaks corresponding to Gly-Hyp and Pro-Hyp on
SIM chromatograms (fig. 4). The levels of urinary
Gly-Hyp and Pro-Hyp in siblings with prolidase de-
ficiency, their mother and normal volunteers were
determined by LC/API-MS and the results are pre-
sented in table 1-B. Although little difference was
found between patients and normal volunteers with
Tab. 1 (A). Amounts of iminodipeptides (X-Pro) in the urines





Fig. 2. The calibration curve for Gly-Pro, showing concentra-
tions plotted against peak areas. The analyses were
performed over a mass range of 0 to 1500, with a scan
rate of 128.0s. The lower detection limit 100 ng for
Gly-Pro by LC/API-MS represents the highest sensitiv-
ity observed in these assays.
Slope: 8.698 · 103
Intercept: - 2.715 · 104
sx: 1.040-10'















































































mean ± SD (n = 5), ND: not detectable
Tab. 1 (B). Amounts of iminodipeptides (X-Hyp) in the urines
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Fig. 3. SIM chromatograms of various iminodipeptides in the urine sample of a patient with prolidase deficiency, the mass
spectrometric conditions were the same as those described in fig. 2.
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Fig. 4. SIM chromatograms of Gly-Hyp ([M -f H]+: 189, arrows) and Pro-Hyp ([M + H]+: 229) in the urines of a patient with
prolidase deficiency, her mother and a normal volunteer. The mass spectrometric conditions were the same as those
described in fig. 2.
respect to Gly-Hyp, patients excreted much more Pro-
Hyp than either their mother or normal volunteers.
No differences in Gly-Hyp or Pro-Hyp excretion were
found between normal volunteers and the patients'
mother, who was heterozygous for the prolidase gene
(19).
As enzymatic activity and excretion of iminodipep-
tides in the urine are closely related, prolidase activity,
particularly towards X^Hyp, is worthy of note. There-
fore prolidase activities against X-Pro and X-Hyp in
erythrocytes from patients, the mother and normal
volunteers were determined by the method described
under Materials and Methods. The prolidase activities
of patients towards Gly-Pro and Pro-Pro were very
low compared with controls, and the mother had
approximately half as much activity as normal vol-
unteers, which agreed with a previous report (19). The
prolidase activities of patients towards Gly-Hyp and
Pro-Hyp were much lower than those towards Gly-
Pro and Pro-Pro. It was also found that even in
normal volunteers, prolidase activities towards Gly-
Hyp and Pro-Hyp are extremely low, and that the
prolidase activities of the patients' mother towards
both X-Hyp and X-Pro are about one half of the
control values (tab. 2).
Tab. 2. Prolidase activities towards Gly-Pro, Gly-Hyp, Pro-Pro
and Pro-Hyp in the erythrocytes of patients, their



























mean ± SD (n = 5), ND: not detectable
Discussion
Previously used procedures employing acid hydrolysis
or enzymatic digestion, followed by amino acid anal-
ysis, were unable to directly identify and quantify
iminodipeptides containing a C-terminal proline or
hydroxyproline in the urine of patients with hereditary
prolidase deficiency. However, the LC/API-MS sys-
tem used in this study distinguished between X-Pro
and Pro-X on a mass chromatogram and mass spec-
trum, and is therefore suitable for the exact identifi-
cation of urinary iminodipeptides. This apparatus,
moreover, performed rapid simultaneous quantitative
analyses of several iminodipeptides. Quantification of
urinary iminodipeptides (X-Pro) revealed that a pa-
tient with severe dermatitis excreted more iminodi-
peptides than her younger sibling with few clinical
symptoms. Collagen metabolism can be closely related
to inflammation, and it may be reflected in the excre-
tion of iminodipeptides in urine. Human prolidase
consists of two isozymes (prolidase I and II) which
are different in substrate specificity and in some bi-
ochemical characteristics. Prolidase deficiency in-
volves a complete deficiency of prolidase I, which
shows the highest activity towards Gly-Pro. Prolidase*
II, which is active mainly against Met-Pro, shows the
same activity in patients as in normal controls. Com-
plete digestion of Met-Pro by prolidase II seems to
be the reason why Met-Pro cannot be detected at all
in urine samples from patients (tab. 1).
The present investigations revealed that not only the
patients but also their mother and normal volunteers
excreted Gly-Hyp and Pro-Hyp into the urine. The
patients excreted more Pro-Hyp than either their
mother or controls. There was little difference between
the excretion of Gly-Hyp by patients and controls.
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and this may reflect the limited production of Gly-
Hyp from collagen, which contains far more Pro-Hyp
than Gly-Hyp. Furthermore, there was no quantita-
tive difference between the X-Hyp excretion of mother
and controls (tab. 1-B). This interesting finding is in
agreement with the measured prolidase activities. The
assay of prolidase activities towards Gly-Pro, Gly-
Hyp, Pro-Pro and Pro-Hyp in the erythrocytes of
patients, their mother and controls showed that the
patients' prolidase (prolidase II) activities towards
Gly-Hyp and Pro-Hyp were much lower than those
towards Gly-Pro and Pro-Pro, which in turn were
very low compared with those of controls. Even in
controls, prolidase (prolidase I and II) activities to-
wards Gly-Hyp and Pro-Hyp were extremely low in
comparison with those towards Gly-Pro and Pro-Pro.
The mother's prolidase activities towards X-Pro and
X-Hyp were about one half of those of normal con-
trols (tab. 2). These results suggest that the mother's
halved activities can hydrolyse all the iminodipeptides
containing a C-terminal proline, which are produced
by the metabolism of collagen, so that X-Pro cannot
be detected in her urine. However, low prolidase ac-
tivities towards X-Hyp in the mother and normal
volunteers were not sufficient for1 the hydrolysis of all
the endogenous iminodipeptides containing a C-ter-
minal hydroxyproline, so that small amounts of un-
hydrolysed Gly-Hyp and Pro-Hyp are found in their
urines.
This report shows that LC/API-MS (SIM mode) is
very suitable for the detection and quantification of
urinary peptides, even in very small amounts.
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